Paul C Roberts Selected Research

di-beta-(morpholinoethyl)selenide (MOSE)

10/2014	Ovarian tumor-initiating cells display a flexible metabolism.
7/2014	Biomechanical profile of cancer stem-like/tumor-initiating cells derived from a progressive ovarian cancer model.
6/2013	Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.
6/2013	Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model.
1/2013	In vitro model of spontaneous mouse OSE transformation.
1/2013	Investigating dielectric properties of different stages of syngeneic murine ovarian cancer cells.
1/2012	The effects of cancer progression on the viscoelasticity of ovarian cell cytoskeleton structures.
3/2011	Changes in gene expression and cellular architecture in an ovarian cancer progression model.
10/2005	Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul C Roberts Research Topics

Disease

11	Ovarian Neoplasms (Ovarian Cancer) 12/2016 - 10/2005
11	Neoplasms (Cancer) 01/2016 - 03/2009
7	Human Influenza (Influenza) 01/2019 - 01/2009
4	COVID-19 01/2022 - 12/2020
4	Virus Diseases (Viral Diseases) 01/2019 - 04/2009
3	Infections 01/2022 - 01/2018
2	Breakthrough Infections 01/2022 - 10/2021
2	Tics (Tic) 10/2014 - 07/2014
2	Carcinogenesis 01/2013 - 01/2006
1	Swine Diseases (Disease, Swine) 01/2018
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2018
1	Peritoneal Diseases 01/2016
1	Colitis 06/2013
1	Obesity 06/2013
1	Breast Neoplasms (Breast Cancer) 10/2011
1	Pneumonia (Pneumonitis) 08/2010
1	Cytokine Release Syndrome 08/2010
1	Influenza in Birds (Avian Flu) 04/2009
1	Colonic Neoplasms (Colon Cancer) 03/2009
1	Sepsis (Septicemia) 06/2007

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2022 - 01/2009
9	di-beta-(morpholinoethyl)selenide (MOSE)IBA 10/2014 - 10/2005
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019 - 04/2009
5	SphingosineIBA 07/2014 - 06/2013
5	SphingolipidsIBA 11/2013 - 03/2009
3	2019-nCoV Vaccine mRNA-1273IBA 01/2022 - 10/2021
3	CytokinesIBA 01/2018 - 08/2010
2	COVID-19 VaccinesIBA 01/2022 - 10/2021
2	Ad26COVS1IBA 01/2022 - 10/2021
2	BNT162 VaccineIBA 01/2022 - 10/2021
2	Interleukin-12 (IL 12)IBA 01/2016 - 02/2014
2	Chemotactic FactorsIBA 01/2016 - 11/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2014 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 06/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2014 - 06/2013
2	Interleukin-2 (IL2)IBA 05/2014 - 04/2009
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 06/2013 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 04/2009 - 06/2007
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Attenuated VaccinesIBA 01/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2016
1	AICA ribonucleotide (ZMP)IBA 10/2014
1	Adenosine Triphosphate (ATP)IBA 10/2014
1	Metformin (Glucophage)FDA LinkGeneric 10/2014
1	OligomycinsIBA 10/2014
1	InterleukinsIBA 05/2014
1	Interleukin-4 (Interleukin 4)IBA 05/2014
1	Inactivated VaccinesIBA 02/2014
1	4- cyclohexyl- 1- (1,2- diphenylethyl)piperazine (cdep)IBA 06/2013
1	Plant Growth Regulators (Plant Hormones)IBA 06/2013
1	Abscisic AcidIBA 06/2013
1	tubastatin AIBA 05/2012
1	Pharmaceutical PreparationsIBA 05/2012
1	Vorinostat FDA Link 05/2012
1	Biopolymers (Biopolymer)IBA 05/2012
1	CeramidesIBA 01/2012
1	SiliconIBA 10/2011
1	Histone Deacetylase InhibitorsIBA 10/2011
1	PPAR gammaIBA 08/2010
1	PPAR-gamma AgonistsIBA 08/2010
1	CarcinogensIBA 03/2009
1	beta CateninIBA 03/2009
1	SphingomyelinsIBA 03/2009
1	DimethylhydrazinesIBA 03/2009
1	Biomarkers (Surrogate Marker)IBA 03/2009
1	Antiviral Agents (Antivirals)IBA 01/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 10/2005
1	Cadherins (E-Cadherin)IBA 10/2005

Therapy/Procedure

2	Therapeutics 10/2014 - 08/2010
1	Immunomodulation 01/2016
1	Aftercare (After-Treatment) 01/2012